Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Pulmonology
•
Diffuse Parenchymal Lung Disease
•
IPF
How do you counsel patients regarding prognosis following a diagnosis of IPF?
Related Questions
Do you seek pathologic confirmation before proceeding with empiric immunosuppressive therapy in symptomatic patients with radiographic NSIP?
What criteria do you use to decide when to perform a BAL in hypersensitivity pneumonitis?
In a patient with low titer +anti-SAE antibody and known ILD, but no other clinical features of dermatomyositis, how would you approach further testing or would you treat the patient as dermatomyositis associated ILD?
How would you approach management of a patient with seropositive RA and UIP-ILD, with concern for active lung disease?
What is your approach to managing ILD associated with inflammatory bowel disease?
How long after initiating mycophenolate do you wait before tapering prednisone off in patients with myositis-associated ILD?
What is your approach to evaluating amiodarone induced interstitial pneumonitis?
Have you adopted the use of low dose morphine for treatment of cough in patients with IPF?
How do you approach a patient with sarcoidosis who cannot tolerate steroids and who is developing ILD?
What is the duration of steroids that you prescribe for organizing pneumonia?
